In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor

In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor

Leukemia Research

Saved in:
Bibliographic Details
Main Authors: Zhou, J., Khng, J., Jasinghe, V.J., Bi, C., Poon, L.F., Xie, Z., Chen, C.-S., Neo, C.H.S., Pan, M., Yu, H., Yeoh, A.E.-J., Lu, Y., Glaser, K.B., Albert, D.H., Davidsen, S.K.
Other Authors: PHYSIOLOGY
Format: Article
Published: 2011
Subjects:
Acute myeloid leukemia
In vivo
Tyrosine kinase inhibitor
Whole-body imaging technology
Wild-type FLT3 receptor
Online Access:http://scholarbank.nus.edu.sg/handle/10635/25091
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Similar Items

Similar Items